Transgender adolescents rarely chose to discontinue gender-affirming hormone therapy, finds study

FHS
June 18, 2023
5:18 pm

A three-year-long retrospective cohort study of a single Atlanta hospital’s patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Combat Health Misinformation with Conversational Intelligence

Amy Brown, Founder & CEO of Authenticx The digital era presents healthcare leaders with a formidable challenge: a tidal wave of online health misinformation shaping

August 19, 2024

Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights

Why are biotech investors so interested in autoimmune disease? Who is behind the telehealth GLP-1 boom? And what were our favorite moments from the STAT

October 17, 2024

TAVI patients with coronary artery disease can derive benefits from percutaneous coronary intervention

Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic valve

September 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.